Clinic
J Fails, LLC
J Fails, LLC was paid $633K by Medicaid between Jul 2021 and Dec 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoJ FAILS, LLC
LUCEDALE, MS 39452
LUCEDALE, MS 39452
33aNPI1851980379assigned 01/11/2021
33bProvider typePrimary Care Clinic/Center
28Total paid$633K
24GClaims22,282
24DCodes billed46
24AFirst – last monthJul 2021 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Mississippi
Rank by total paid#16 of 85
Median peer was paid$100K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,588 | $56K | |
| 2022 | 7,828 | $210K | |
| 2023 | 7,392 | $228K | |
| 2024incomplete | 4,474 | $138K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 5,440 | 4,626 | $282K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 1,358 | 1,201 | $104K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.1% | 2,084 | 1,772 | $58K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.4% | 484 | 460 | $34K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 369 | 348 | $26K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.0% | 2,906 | 1,419 | $25K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 468 | 374 | $24K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.0% | 853 | 707 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 1,771 | 1,519 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 226 | 208 | $9K |
| 87807 | <1% | 723 | 601 | $5K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 159 | 151 | $5K |
34 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 41 | $3K |
| D1206 | Topical application of fluoride varnish | <1% | 147 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 510 | $3K |
| 92551 | <1% | 590 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 119 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 183 | $2K |
| 92567 | <1% | 231 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 70 | $1K |
| 90670 | <1% | 169 | $1K | |
| 96127 | <1% | 331 | $915.90 | |
| 99382 | <1% | 15 | $654.37 | |
| 99173 | <1% | 562 | $480.53 | |
| 99383 | <1% | 24 | $391.60 | |
| 85018 | <1% | 260 | $389.42 | |
| 94664 | <1% | 38 | $316.97 | |
| 99188 | <1% | 788 | $298.27 | |
| 83655 | <1% | 25 | $245.25 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $120.90 |
| 90647 | <1% | 125 | $70.83 | |
| 81002 | <1% | 26 | $70.50 | |
| 99442 | <1% | 18 | $56.10 | |
| 97802 | <1% | 171 | $24.00 | |
| 90461 | <1% | 499 | $21.20 | |
| 96161 | <1% | 23 | $14.81 | |
| 94760 | <1% | 15 | $3.20 | |
| 96160 | <1% | 42 | $1.75 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 36 | $0.01 |
| 90723 | 0% | 114 | $0.00 | |
| 90680 | 0% | 44 | $0.00 | |
| 90686 | 0% | 39 | $0.00 | |
| 90677 | 0% | 96 | $0.00 | |
| 90648 | 0% | 16 | $0.00 | |
| 90633 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFAILS, JENNIFER (OWNER)